We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$5.69B
AUM Growth
+$1.12B
Cap. Flow
+$931M
Cap. Flow %
16.36%
Top 10 Hldgs %
68.83%
Holding
427
New
58
Increased
49
Reduced
125
Closed
113

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$369M
2
CAT icon
Caterpillar
CAT
+$252M
3
DE icon
Deere & Co
DE
+$236M
4
AMZN icon
Amazon
AMZN
+$170M
5
NFLX icon
Netflix
NFLX
+$167M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$191M
2
WFC icon
Wells Fargo
WFC
+$174M
3
C icon
Citigroup
C
+$163M
4
BAC icon
Bank of America
BAC
+$161M
5
TSM icon
TSMC
TSM
+$17.5M

Sector Composition

Rank Sector Weight
1 Technology 27.18%
2 Energy 17.43%
3 Industrials 17.37%
4 Financials 9.43%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
251
PUT
Amazon
AMZN
$2.86T
$28.3K ﹤0.01%
480
+300
+167% +$34.3K
CVLT icon
252
Commault Systems
CVLT
$6.26B
$28.2K ﹤0.01%
389
-133
-25% -$8.64K
DLB icon
253
Dolby
DLB
$5.84B
$28K ﹤0.01%
335
-30
-8% -$2.51K
ALKS icon
254
Alkermes
ALKS
$8.3B
$28K ﹤0.01%
+895
New +$27.1K
SNPS icon
255
Synopsys
SNPS
$78.8B
$27.9K ﹤0.01%
+64
New +$25.8K
RMBS icon
256
Rambus
RMBS
$10.8B
$27.9K ﹤0.01%
434
-258
-37% -$14.2K
IRMD icon
257
iRadimed
IRMD
$1.11B
$27.6K ﹤0.01%
+578
New +$26.1K
EXEL icon
258
Exelixis
EXEL
$12.5B
$27.6K ﹤0.01%
+1,442
New +$27.8K
USNA icon
259
Usana Health Sciences
USNA
$252M
$27.4K ﹤0.01%
+434
New +$27.6K
MMSI icon
260
Merit Medical Systems
MMSI
$5.4B
$27.3K ﹤0.01%
+326
New +$26.5K
BRKR icon
261
Bruker
BRKR
$8.83B
$27.2K ﹤0.01%
368
-40
-10% -$3.05K
PRGS icon
262
Progress Software
PRGS
$1.83B
$27K ﹤0.01%
465
-67
-13% -$3.81K
INTA icon
263
Intapp
INTA
$3.16B
$26.9K ﹤0.01%
643
-85
-12% -$3.66K
LNTH icon
264
Lantheus
LNTH
$6.59B
$26.9K ﹤0.01%
+320
New +$28.7K
OSIS icon
265
OSI Systems
OSIS
$3.77B
$26K ﹤0.01%
+221
New +$25.4K
NIOBW
266
NioCorp Developments Ltd Warrant
NIOBW
$76.4M
$26K ﹤0.01%
40,000
PLX icon
267
Protalix BioTherapeutics
PLX
$190M
$24.3K ﹤0.01%
12,142
SATL icon
268
Satellogic
SATL
$906M
$24.1K ﹤0.01%
171,946
CFFSW
269
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$22.6K ﹤0.01%
152,029
ATEK.WS
270
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$22.5K ﹤0.01%
449,999
GWW icon
271
W.W. Grainger
GWW
$62.2B
$20.5K ﹤0.01%
26
-126
-83% -$86.8K
RS icon
272
Reliance Steel & Aluminium
RS
$21.7B
$19.8K ﹤0.01%
73
-799
-92% -$198K
FAST icon
273
Fastenal
FAST
$58.9B
$19.8K ﹤0.01%
+670
New +$18.3K
HUBB icon
274
Hubbell
HUBB
$26.8B
$19.6K ﹤0.01%
59
-20
-25% -$5.54K
LECO icon
275
Lincoln Electric
LECO
$15.5B
$19.1K ﹤0.01%
96
-37
-28% -$6.45K

Similar funds

Altshuler Shaham's Q2 2023 Portfolio in Review

As of Q2 2023, Altshuler Shaham held 427 positions worth $5.69B, up 24% from $4.57B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Altshuler Shaham deployed $931M of net new capital in Q2 2023, opening 58 new positions and adding to 49 existing holdings. Its largest new stake was 3M: 1,109,161 shares worth $92.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 20% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $191M trimmed.

  • Altshuler Shaham's largest Q2 2023 buy was 3M: 1,109,161 shares worth $92.8M.
  • Altshuler Shaham added most to Apple in Q2 2023, an estimated $369M increase.
  • Altshuler Shaham's biggest Q2 2023 reduction was JPMorgan Chase, cutting an estimated $191M.
  • Altshuler Shaham fully exited KLA in Q2 2023, selling an estimated $1.16M.
  • Altshuler Shaham's ten largest holdings make up 69% of its $5.69B portfolio in Q2 2023.
  • Altshuler Shaham opened 58 new positions and closed 113 in Q2 2023.
  • Altshuler Shaham's portfolio value rose 24% quarter-over-quarter to $5.69B.

Based on Altshuler Shaham's 13F filing for Q2 2023, filed 24 Jul 2023.